Quintieri L - Search Results

1

Prolonging the stability of cetuximab (Erbitux®) and panitumumab (Vectibix®): An orthogonal assessment of physicochemical, biological and microbiological properties of original opened glass vials and diluted saline preparations.

Carpanese D, Rossi V, Di Paolo V, Quintieri L, Penna A, Zuccolotto G, Sebellin J, Saran C, Pipitone F, Miolo G, De Diana E, Realdon N, Rigamonti N, Di Sarra F, Coppola M, Rosato A. Carpanese D, et al. Among authors: quintieri l. Int J Pharm. 2024 Jan 5;649:123643. doi: 10.1016/j.ijpharm.2023.123643. Epub 2023 Nov 30. Int J Pharm. 2024. PMID: 38040395 Free article.

2

Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitro.

Quintieri L, Bortolozzo S, Stragliotto S, Moro S, Pavanetto M, Nassi A, Palatini P, Floreani M. Quintieri L, et al. Drug Metab Pharmacokinet. 2010;25(5):466-76. doi: 10.2133/dmpk.dmpk-10-rg-044. Epub 2010 Sep 22. Drug Metab Pharmacokinet. 2010. PMID: 20877134 Free article.

3

Hyperthermic isolated perfusion with low-dose TNFalpha and doxorubicin in patients with locally advanced soft tissue limb sarcomas.

Rossi CR, Foletto M, Mocellin S, Pilati P, Quintieri L, De Salvo GL, Nitti D, Lise M. Rossi CR, et al. Among authors: quintieri l. J Chemother. 2004 Nov;16 Suppl 5:58-61. doi: 10.1080/1120009x.2004.11782387. J Chemother. 2004. PMID: 15675481 Clinical Trial.

4

Inhibition of cytochrome P450 2C8-mediated drug metabolism by the flavonoid diosmetin.

Quintieri L, Palatini P, Moro S, Floreani M. Quintieri L, et al. Drug Metab Pharmacokinet. 2011;26(6):559-68. doi: 10.2133/dmpk.DMPK-11-RG-048. Epub 2011 Jul 26. Drug Metab Pharmacokinet. 2011. PMID: 21791871 Free article.

5

Metabolic effects of antiangiogenic drugs in tumors: therapeutic implications.

Quintieri L, Selmy M, Indraccolo S. Quintieri L, et al. Biochem Pharmacol. 2014 May 15;89(2):162-70. doi: 10.1016/j.bcp.2014.02.018. Epub 2014 Mar 4. Biochem Pharmacol. 2014. PMID: 24607274 Review.

6

Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes.

Quintieri L, Palatini P, Nassi A, Ruzza P, Floreani M. Quintieri L, et al. Biochem Pharmacol. 2008 Mar 15;75(6):1426-37. doi: 10.1016/j.bcp.2007.11.012. Epub 2007 Dec 4. Biochem Pharmacol. 2008. PMID: 18191104

7

Pharmacokinetics of intraperitoneal cisplatin and doxorubicin.

Rossi CR, Mocellin S, Pilati P, Foletto M, Quintieri L, Palatini P, Lise M. Rossi CR, et al. Among authors: quintieri l. Surg Oncol Clin N Am. 2003 Jul;12(3):781-94. doi: 10.1016/s1055-3207(03)00030-9. Surg Oncol Clin N Am. 2003. PMID: 14567031 Review.

8

Identification of molecular determinants of tumor sensitivity and resistance to anticancer drugs.

Quintieri L, Fantin M, Vizler C. Quintieri L, et al. Adv Exp Med Biol. 2007;593:95-104. doi: 10.1007/978-0-387-39978-2_10. Adv Exp Med Biol. 2007. PMID: 17265720 Review.

9

R-warfarin anticoagulant effect.

Padrini R, Quintieri L. Padrini R, et al. Among authors: quintieri l. Br J Clin Pharmacol. 2017 Oct;83(10):2303-2304. doi: 10.1111/bcp.13300. Epub 2017 May 11. Br J Clin Pharmacol. 2017. PMID: 28493597 Free PMC article. No abstract available.

10

Carteolol, a non-conventional partial agonist of beta(1)-adrenoceptors, relaxes phenylephrine-constricted rat aorta through antagonism at alpha(1)-adrenoceptors.

Floreani M, Quintieri L, Varani K, Dorigo MT, Dorigo P. Floreani M, et al. Among authors: quintieri l. Eur J Pharmacol. 2008 Aug 20;590(1-3):269-75. doi: 10.1016/j.ejphar.2008.05.023. Epub 2008 May 24. Eur J Pharmacol. 2008. PMID: 18571646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters